Nordson (NDSN) PT Raised to $276 at Jefferies

Nordson (NDSN) Guidance Increase is Underwhelming, Morgan Stanley Reiterates Equalweight

Morgan Stanley analyst Connor Lynagh reiterated an Equalweight rating and $230.00 price target on Nordson (NASDAQ: NDSN) after the company posted another record quarter of results and backlog, and raised guidance to reflect stronger customer activity. Results for 3Q of $647MM / $2.42 beat consensus of $604MM /... More

Pre-Open Stock Movers 08/31: (ACIU) (SONN) (APPS) Higher; (ZM) (AMWD) (CHS) Lower (more...)

Pre-Open Stock Movers:

AC Immune SA (NASDAQ: ACIU) 74.5% HIGHER; announced that Genentech, a member of the Roche Group, has informed the Company that Lauriet, a placebo-controlled Phase 2 study evaluating the safety and efficacy of the investigational anti-tau monoclonal antibody, semorinemab, in mild-to-moderate Alzheimers disease (AD), met one of its co-primary endpoints, ADAS-Cog11. The second co-primary endpoint, ADCS-ADL, was not met. Safety data showed that semorinemab is well tolerated with an acceptable safety profile and no unanticipated safety signals.

Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:... More

After-Hours Stock Movers 08/30: (SONN) (APPS) (PFGC) Higher; (ZM) (STNE) (SOL) Lower (more...)

After-Hours Movers:

Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) 27% HIGHER; announced today that it has selected a novel development candidate after completing comparative studies in a mouse melanoma model. The candidate represents Sonnet's second bispecific compound integrating Interleukin 12 (IL-12) with the company's Fully Human Albumin Binding (FHAB) platform. The target indications for SON-1410 will be melanoma and renal cancers.

Zoom (NASDAQ: ZM) 11.5% LOWER; reported Q2 EPS of $1.36, $0.34 better... More

Nordson Corp. (NDSN) Tops Q3 EPS by 36c; Raises Outlook

Nordson Corp. (NASDAQ: NDSN) reported Q3 EPS of $2.42, $0.36 better than the analyst estimate of $2.06. Revenue for the quarter came in at $647 million versus the consensus estimate of $602.66 million.

GUIDANCE:

Nordson Corp. raises FY2021 EPS to $7.75-$7.95, versus the consensus of... More